Key result
Stimulation of CD95 in T and B cell lines leads to the formation of a novel cytosolic death effector domain protein-containing complex (complex II) that may amplify caspase activation.
CD95 signaling involves a two-step process, with the second step forming a cytosolic complex II that may amplify caspase activation.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications for CD95 therapies; leaves open in vivo relevance of complex II for caspase amplification.
Stimulation of CD95 (APO-1/Fas) by its natural ligand CD95L (APO-1L/FasL) leads to the formation of the death-inducing signaling complex. Here we report that upon CD95 stimulation in several T and B cell lines, a novel signaling complex is formed, which we term complex II. Complex II is composed of the death effector domain proteins as follows: procaspase-8a/b, three isoforms of c-FLIP (c-FLIP(L), c-FLIP(S), c-FLIP(R)), and FADD. Notably, complex II does not contain CD95. Based on our findings we suggest that CD95 signaling includes two steps. The first step involves formation of the death-inducing signaling complex at the cell membrane. The second step involves formation of the cytosolic death effector domain protein-containing complex that may play an important role in amplification of caspase activation.
No takes yet. Share an insight, caveat, or question.
Lavrik et al. (2008) studied this question. CD95 stimulation was evaluated on Formation of complex II. Stimulation of CD95 in T and B cell lines leads to the formation of a novel cytosolic death effector domain protein-containing complex (complex II) that may amplify caspase activation.
Synapse has enriched 10 related papers. Consider them for comparative context: